首页 | 本学科首页   官方微博 | 高级检索  
检索        


Formaldehyde dehydrogenase: Beyond phase I metabolism
Authors:Chad M Thompson  Rebecca Ceder  Roland C Grafström
Institution:1. ToxStrategies, Inc., 23501 Cinco Ranch Blvd., Suite G265, Katy, TX 77494, United States;2. Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden;3. VTT Technical Research Centre of Finland, Medical Biotechnology, P.O. Box 106, FI-20521 Turku, Finland
Abstract:Formaldehyde dehydrogenase, formally Class III alcohol dehydrogenase (ADH3), has recently been discovered to partially regulate nitrosothiol homeostasis by catalyzing the reduction of the endogenous nitrosylating agent S-nitrosoglutathione (GSNO). Several studies have implicated this enzyme, and in particular GSNO reduction, as playing an important role in conditions such as asthma, cardiovascular disease, and immune function. While ADH3 has received considerable attention in the biomedical literature where it is often referred to as GSNO reductase (GSNOR), ADH3-mediated GSNO reduction has received comparatively less attention in the environmental toxicology community. Herein, evidences for a role of ADH3 in cell signaling through thiol homeostasis is highlighted, underscoring that the enzyme functions more broadly than to metabolize formaldehyde.
Keywords:Formaldehyde  Formaldehyde dehydrogenase  Alcohol dehydrogenase 3  ADH3  GSNO  GSNO reductase  GSNOR
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号